Concepedia

Edward Tuttle

ET

Statistics

Publications

15

Citations

884

H-Index

13

Active since

2005

Affiliations

Analysis Group (United States)(Current)

Sarepta Therapeutics (United States)

Menlo School

University of California Davis Medical Center

Intarcia Therapeutics (United States)

Edward Tuttle is an author at Analysis Group (United States) specializing in medicine, pharmacotherapy, and clinical pharmacology.

Publications per year

2005–2024

15

Publications

15

Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014

Ginger Smith Carls, Johnny Huynh, Edward Tuttle et al. · Diabetes Therapy · 2017 · 241 citations · Full text

, , +16

Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes

Ginger Smith Carls, Edward Tuttle, Ruoding Tan et al. · Diabetes Care · 2017 · 155 citations

, , +17

Economic burden and co‐morbidities of atrial fibrillation in a privately insured population

Eric Q. Wu, Howard G. Birnbaum, Milena N. Mareva et al. · Current Medical Research and Opinion · 2005 · 126 citations

, , +17

Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind?

David S. Bach, Jasmina I. Radeva, Howard G. Birnbaum et al. · PubMed · 2007 · 106 citations

, , +17

Effects of Metreleptin on Patient Outcomes and Quality of Life in Generalized and Partial Lipodystrophy

Keziah Cook, Kelly Adamski, Aparna Gomes et al. · Journal of the Endocrine Society · 2021 · 39 citations · Full text

, , +17

1–5 of 15